menu search

Rising global uti cases and multidrug-resistant bacteria: fueling the urinary tract infection testing market to us$ 1.1 billion by 2033 | future market insights

Urinary tract infection (UTI) is a widespread infectious disease caused by bacteria, particularly complicated UTI (cUTI) due to urinary system abnorma...

August 4, 2023, 12:30 am

Metformin treatment may decrease the mortality risk in icu patients with type 2 diabetes and chf

Patients receiving intensive care often have diabetes mellitus (DM) together with chronic heart failure...

June 27, 2023, 7:02 pm

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ

Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...

June 24, 2023, 1:54 am

Pfizer v medical properties: covid-19 vaccines give pfizer an edge

Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...

February 19, 2022, 6:54 pm

Pfizer v medical properties: covid-19 vaccines give pfizer an edge

Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...

February 19, 2022, 6:54 pm

Pfizer v medical properties: covid-19 vaccines give pfizer an edge

Pfizer Inc Pfizer Inc. (NYSE:PFE) is a company that manufactures and markets biopharmaceutical products worldwide. They provide medications for variou...

February 19, 2022, 6:54 pm


Search within

Pages Search Results: